1996
DOI: 10.1016/0014-5793(95)01539-6
|View full text |Cite
|
Sign up to set email alerts
|

Degradation of cartilage aggrecan by collagenase‐3 (MMP‐13)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

9
217
1
1

Year Published

1998
1998
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 344 publications
(228 citation statements)
references
References 41 publications
9
217
1
1
Order By: Relevance
“…MMP-13 has a particular affinity for type II collagen and selectively enhances cleavage and denaturation of this type of collagen (43), and can also cleave aggrecan at specific sites (44). Interestingly, recent studies have also shown that retinoid-related signals strongly enhance the induction of MMP-13 in chondrocytic cells through the action of RAR-RXR heterodimers (45).…”
Section: Discussionmentioning
confidence: 99%
“…MMP-13 has a particular affinity for type II collagen and selectively enhances cleavage and denaturation of this type of collagen (43), and can also cleave aggrecan at specific sites (44). Interestingly, recent studies have also shown that retinoid-related signals strongly enhance the induction of MMP-13 in chondrocytic cells through the action of RAR-RXR heterodimers (45).…”
Section: Discussionmentioning
confidence: 99%
“…Both in human articular chondrocytes and spine discs, it appears that the activation of multiple MAPK pathways (ERK, JNK, and p38) is required for the expression of MMP-13 after stimulation with inflammatory cytokines and growth factors such as IL-1 and bFGF Muddasani et al, 2007;Li et al, 2008). Clinically, stringent regulation of MMP-13 within the chondrocytic cell signaling network, through a complex interplay of regulatory factors and elements, may be necessary given the potent degrading activity of MMP-13 against a wide spectrum of substrates in the ECM and its pivotal role when present in excess amounts in OA cartilage (Fosang et al, 1996;Mitchell et al, 1996).…”
Section: (C) Extracellular Signaling Mediated By Bfgfmentioning
confidence: 99%
“…Among the collagenases, collagenase-3 (MMP-13) has been found to play a significant role in the development of both OA and DDD (Billinghurst et al, 1997;Fernandes et al, 1998;Anderson et al, 2002;Le Maitre et al, 2004). In articular cartilage, MMP-13 is almost exclusively produced by chondrocytes and has a dual role in ECM *Correspondence to : Hee-Jeong Im, Ph.D., Cohn Research BD 516, 1735 W. Harrison, Chicago, IL 60612, 312-942-3091 (Tel), 312-942-3053 (fax), Email : Hee-Jeong_Sampen@rush.edu.destruction as it degrades bothaggrecan and collagen type II (Fosang et al, 1996;Mitchell et al, 1996;Reboul et al, 1996;Fernandes et al, 1998). In the IVD, MMP-13 expression increases with increasing severity of disc degeneration (Le Maitre et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…In support of this contention, a strong correlation exists between specific cleavage of the aggrecan core protein at the Glu373-Ala374 bond and the release of aggrecan catabolites in response to IL-1: 6 fragments bearing this epitope are found in synovial fluids of OA patients. 7 In addition, cells from OA synovium produce more IL-1b than normal synovium, 8,9 and similarly, chondrocytes for OA cartilage secrete both IL-1a and IL-1b unlike normal chondrocytes. 10,11 It is also known that OA cartilage explants are more susceptible to the effects of IL-1 than similar explants from nonarthritic cartilage 12 and that this susceptibility is related to the expression of IL-1 receptor types 1 and 2 on chondrocytes.…”
Section: Introductionmentioning
confidence: 99%